Carnegie Asset Management

Summary

The main department of described VC is located in the Copenhagen. The company was established in Europe in Denmark.

The usual cause for the fund is to invest in rounds with 6 partakers. Despite the Carnegie Asset Management, startups are often financed by MVI Finance, HBM Healthcare Investments AG, NGN Capital. The meaningful sponsors for the fund in investment in the same round are The Dow Chemical Company, NGN Capital, MVI Finance. In the next rounds fund is usually obtained by HBM Healthcare Investments AG, Biotech Turnaround Fund (BTF), YA Global Master SPV.

Besides them, we counted 5 critical employees of this fund in our database.

Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Genizon BioSciences, Santhera Pharmaceuticals, ZoomON. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. We can highlight the next thriving fund investment areas, such as Business Development, Genetics.

Considering the real fund results, this VC is 3 percentage points less often commits exit comparing to other organizations. The common things for fund are deals in the range of 10 - 50 millions dollars. Opposing the other organizations, this Carnegie Asset Management works on 4 percentage points more the average amount of lead investments. The fund is generally included in less than 2 deals every year. The top activity for fund was in 2006. The increased amount of exits for fund were in 2007.